Author:
Hegge I. R. H. J.,Kaspers G. J. L,Rots M. G.,Jansen G.,Pieters R.,Veerman A. J. R
Reference10 articles.
1. Kaspers GJL, Pieters R, Van Zantwijk CH, Van Wering ER, Van der Does-van den Berg A, Veerman AJP. Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs. Blood 1998, 92:259–266
2. Bleyer WA, Dedrick RL. Clinical pharmacology of intrathecal methotrexate: I. Pharmacokinetics in non-toxic patients after lumbar injection. Cancer Treatm Rep 1977, 61:703–708
3. Jacobs SA, Bleyer WA, Chabner BA, Johns DG. Altered plasma pharmacokinetics of methotrexate administered intrathecally. Lancet 1975, 1:465–466
4. Simmons ED, Somberg KA. Acute tumor lysis syndrome after intrathecal methotrexate administration. Cancer 1991, 67:2062–2065
5. Thyss A, Suciu S, Bertrand Y, et al. Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. J Clin Oncol 1997, 15:1824–1830
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献